vimarsana.com
  1. Home
  2. Live Updates
  3. EG 427: EG427 Announces New Preclinical Results from Multiple Studies of EG110A in Neurogenic Detrusor Overactivity (NDO) and Overactive Bladder (OAB) : vimarsana.com

EG 427: EG427 Announces New Preclinical Results from Multiple Studies of EG110A in Neurogenic Detrusor Overactivity (NDO) and Overactive Bladder (OAB)

EG 427: EG427 Announces New Preclinical Results from Multiple Studies of EG110A in Neurogenic Detrusor Overactivity (NDO) and Overactive Bladder (OAB)

finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

Paris ,France General ,France ,Sophie Baumont ,Philippe Chambon ,Cohesion Bureau ,Drug Administration ,New Preclinical Results ,Multiple Studies ,Neurogenic Detrusor Overactivity ,Overactive Bladder ,Chief Executive Officer ,Investigational New Drug ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.